Combivent, a metered-dose inhaler that combines two different bronchodilators

Boehringer Ingelheim will soon market Combivent, a metered-dose inhaler that combines two different bronchodilators...the anticholinergic, ipratropium (Atrovent)...and the beta-agonist, albuterol (Ventolin, etc).

Combivent is for chronic obstructive pulmonary disease (COPD). It'll be used as SECOND-LINE therapy...for patients who don't do well on either bronchodilator alone.

Don't use Combivent for chronic asthma...there's no benefit from adding ipratropium to inhaled beta-agonists in asthmatics.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote